Medical Center - University of Freiburg
2 ARTICLES PUBLISHED IN JoVE
Medicine
Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis
Rüdiger Braun 1, Olha Lapshyna 1, Susanne Eckelmann 2,3, Kim Honselmann 1, Louisa Bolm 1, Meike ten Winkel 1, Steffen Deichmann 1, Oliver Schilling 4, Charli Kruse 2,3, Tobias Keck 1, Ulrich Wellner 1, Peter Bronsert 4,5,6, Matthias Brandenburger 3
1Department of Surgery, University Medical Center Schleswig-Holstein, 2Institute of Medical and Marine Biotechnology, University of Lübeck, 3Fraunhofer Research and Development Center for Marine and Cellular Biotechnology, 4Institute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, 5Tumorbank Comprehensive Cancer Center Freiburg, Medical Center - University of Freiburg, 6Core Facility Histopathology and Digital Pathology Freiburg, Medical Center - University of Freiburg
This protocol describes the preparation of organotypic slice cultures (OTSCs). This technique facilitates the ex vivo cultivation of intact multicellular tissue. OTSCs can be used immediately to test for their respective response to drugs in a multicellular environment.
Immunology and Infection
Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
Natascha Drude 1, Kai Diederich 2, Claudia U. Duerr 3, Nadine Haase 4, Christoph Harms 5,6,7,8, Frank Heppner 9,10,11, Marina Jendrach 9,10,11, Pia Kahnau 2, Marina Kolesnichenko 12, Lars Lewejohann 2,13, Claudia Kurreck 1, Anke Lohan 14, Marcus A. Mall 15,16, Dominik Müller 4, Stefan Nagel-Riedasch 14, Bastian Opitz 17, Laura Schaupp 15,16, Gilbert Schönfelder 2,18, Amelie Weber 3, Gerald Willimsky 19,20,21, Yalei Zang 1,22, Stephan P. Rosshart *23,24, Andreas Diefenbach *3, Stefan Jordan *3
1BIH QUEST Center for Responsible Research, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, 2German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R), 3Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 4Experimental and Clinical Research Center (ECRC) & Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), 5Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik und Hochschulambulanz für Neurologie, 6Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 7Einstein Center for Neuroscience, 8German Center for Cardiovascular Research (DZHK), partner site Berlin, 9Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10Cluster of Excellence, NeuroCure, 11German Center for Neurodegenerative Diseases (DZNE) Berlin, 12Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13Institute of Animal Welfare, Animal Behavior and Laboratory Animal Science, Freie Universität Berlin, 14Forschungseinrichtungen für Experimentelle Medizin/FEM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 15Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 16German Center for Lung Research (DZL), associated partner site, Berlin, 17Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 18Division of Toxicology, Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 19Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 20German Cancer Research Center, 21German Cancer Consortium, partner site Berlin, 22Department of Radiology (including Pediatric Radiology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 23Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 24Department of Medicine II, Faculty of Medicine, Medical Center - University of Freiburg
Here, we describe the structure and operating procedures, including microbial containment measures of a facility for "Wilding mice" using blood sampling for immunophenotyping as an example.
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır